Quarterly report · Q1
4885.TEDINET S100S0P0
Period2023-06-01 → 2023-08-31
Filed2023-10-13
StandardJapan GAAP
ConsolidatedNo
Data checks10 of 10 passed
Key figures · 36
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥1.5bn | 2023-06-01 → 2023-08-31 | Standalone | Net sales |
| Revenue | ¥6.3bn | 2022-06-01 → 2023-05-31 | Standalone | Net sales (5-year summary) |
| Revenue | ¥1.5bn | 2022-06-01 → 2022-08-31 | Standalone | Net sales |
| Operating income | ¥46m | 2023-06-01 → 2023-08-31 | Standalone | Operating income |
| Operating income | ¥130m | 2022-06-01 → 2022-08-31 | Standalone | Operating income |
| Ordinary income | ¥45m | 2023-06-01 → 2023-08-31 | Standalone | Ordinary income |
| Ordinary income | ¥351m | 2022-06-01 → 2023-05-31 | Standalone | Ordinary income loss (5-year summary) |
| Ordinary income | ¥118m | 2022-06-01 → 2022-08-31 | Standalone | Ordinary income |
| Profit before tax | ¥47m | 2023-06-01 → 2023-08-31 | Standalone | Income before income taxes |
| Profit before tax | ¥118m | 2022-06-01 → 2022-08-31 | Standalone | Income before income taxes |
| Net income | ¥23m | 2023-06-01 → 2023-08-31 | Standalone | Profit loss |
| Net income | ¥256m | 2022-06-01 → 2023-05-31 | Standalone | Net income loss (5-year summary) |
| Net income | ¥86m | 2022-06-01 → 2022-08-31 | Standalone | Profit loss |
| Total assets | ¥4.8bn | at 2023-08-31 | Standalone | Assets |
| Total assets | ¥4.9bn | at 2023-05-31 | Standalone | Assets |
| Total assets | ¥4.8bn | at 2022-08-31 | Standalone | Total assets (5-year summary) |
| Total liabilities | ¥2.9bn | at 2023-08-31 | Standalone | Liabilities |
| Total liabilities | ¥3.0bn | at 2023-05-31 | Standalone | Liabilities |
| Net assets / equity | ¥1.9bn | at 2023-08-31 | Standalone | Net assets |
| Net assets / equity | ¥1.9bn | at 2023-05-31 | Standalone | Net assets |
| Net assets / equity | ¥1.7bn | at 2022-08-31 | Standalone | Net assets (5-year summary) |
| Cash and deposits | ¥715m | at 2023-08-31 | Standalone | Cash and deposits |
| Cash and deposits | ¥853m | at 2023-05-31 | Standalone | Cash and deposits |
| EPS (basic) | ¥5.76 | 2023-06-01 → 2023-08-31 | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥67.94 | 2022-06-01 → 2023-05-31 | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥23.13 | 2022-06-01 → 2022-08-31 | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (diluted) | ¥5.64 | 2023-06-01 → 2023-08-31 | Standalone | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥64.12 | 2022-06-01 → 2023-05-31 | Standalone | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥22.75 | 2022-06-01 → 2022-08-31 | Standalone | Diluted earnings per share (5-year summary) |
| Dividend per share | ¥19 | 2022-06-01 → 2023-05-31 | Standalone | Dividend paid per share (5-year summary) |
| Equity ratio | 39.0% | at 2023-08-31 | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 38.7% | at 2023-05-31 | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 35.7% | at 2022-08-31 | Standalone | Equity to asset ratio (5-year summary) |
| Shares issued | 4,095,500 | at 2023-08-31 | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 4,095,500 | at 2023-05-31 | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 4,095,500 | at 2022-08-31 | Standalone | Total number of issued shares (5-year summary) |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 30
| Segment | Item | Period | Value |
|---|---|---|---|
| jpcrp040300-q1r_E36350-000Chemical Products Businessreportable segment | revenue | 2023-06-01 → 2023-08-31 | ¥472m |
| jpcrp040300-q1r_E36350-000Chemical Products Businessreportable segment | revenue external | 2023-06-01 → 2023-08-31 | ¥472m |
| jpcrp040300-q1r_E36350-000Chemical Products Businessreportable segment | segment profit | 2023-06-01 → 2023-08-31 | −¥34m |
| jpcrp040300-q1r_E36350-000Healthy Food Businessreportable segment | revenue | 2023-06-01 → 2023-08-31 | ¥215m |
| jpcrp040300-q1r_E36350-000Healthy Food Businessreportable segment | revenue external | 2023-06-01 → 2023-08-31 | ¥215m |
| jpcrp040300-q1r_E36350-000Healthy Food Businessreportable segment | segment profit | 2023-06-01 → 2023-08-31 | −¥17m |
| jpcrp040300-q1r_E36350-000Pharmaceutical Businessreportable segment | revenue | 2023-06-01 → 2023-08-31 | ¥829m |
| jpcrp040300-q1r_E36350-000Pharmaceutical Businessreportable segment | revenue external | 2023-06-01 → 2023-08-31 | ¥829m |
| jpcrp040300-q1r_E36350-000Pharmaceutical Businessreportable segment | segment profit | 2023-06-01 → 2023-08-31 | ¥97m |
| —segment total | revenue | 2023-06-01 → 2023-08-31 | ¥1.5bn |
| —segment total | revenue external | 2023-06-01 → 2023-08-31 | ¥1.5bn |
| —segment total | segment profit | 2023-06-01 → 2023-08-31 | ¥46m |
| Total Of Reportable Segments And Otherssegment total | revenue | 2023-06-01 → 2023-08-31 | ¥1.5bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2023-06-01 → 2023-08-31 | ¥1.5bn |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2023-06-01 → 2023-08-31 | ¥46m |
| jpcrp040300-q1r_E36350-000Chemical Products Businessreportable segment | revenue | 2022-06-01 → 2022-08-31 | ¥508m |
| jpcrp040300-q1r_E36350-000Chemical Products Businessreportable segment | revenue external | 2022-06-01 → 2022-08-31 | ¥508m |
| jpcrp040300-q1r_E36350-000Chemical Products Businessreportable segment | segment profit | 2022-06-01 → 2022-08-31 | ¥26m |
| jpcrp040300-q1r_E36350-000Healthy Food Businessreportable segment | revenue | 2022-06-01 → 2022-08-31 | ¥241m |
| jpcrp040300-q1r_E36350-000Healthy Food Businessreportable segment | revenue external | 2022-06-01 → 2022-08-31 | ¥241m |
| jpcrp040300-q1r_E36350-000Healthy Food Businessreportable segment | segment profit | 2022-06-01 → 2022-08-31 | −¥711,000 |
| jpcrp040300-q1r_E36350-000Pharmaceutical Businessreportable segment | revenue | 2022-06-01 → 2022-08-31 | ¥778m |
| jpcrp040300-q1r_E36350-000Pharmaceutical Businessreportable segment | revenue external | 2022-06-01 → 2022-08-31 | ¥778m |
| jpcrp040300-q1r_E36350-000Pharmaceutical Businessreportable segment | segment profit | 2022-06-01 → 2022-08-31 | ¥105m |
| —segment total | revenue | 2022-06-01 → 2022-08-31 | ¥1.5bn |
| —segment total | revenue external | 2022-06-01 → 2022-08-31 | ¥1.5bn |
| —segment total | segment profit | 2022-06-01 → 2022-08-31 | ¥130m |
| Total Of Reportable Segments And Otherssegment total | revenue | 2022-06-01 → 2022-08-31 | ¥1.5bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2022-06-01 → 2022-08-31 | ¥1.5bn |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2022-06-01 → 2022-08-31 | ¥130m |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 360
| Item | Context | Value | Unit |
|---|---|---|---|
| Notes regarding dividend (text) | Prior1YTDDuration_NonConsolidatedMember | Text · Plus | |
| Notes regarding dividend (text) | CurrentYTDDuration_NonConsolidatedMember | Text · Plus | |
| Notes segment information etc quarterly financial statements (text) | CurrentYTDDuration | Text · Plus | |
| Footnotes regarding segment information table (text) | Prior1YTDDuration_NonConsolidatedMember | Text · Plus | |
| Footnotes regarding segment information table (text) | CurrentYTDDuration_NonConsolidatedMember | Text · Plus | |
| Notes revenue recognition quarterly financial statements (text) | CurrentYTDDuration | Text · Plus | |
| Notes per share information quarterly financial statements (text) | CurrentYTDDuration | Text · Plus | |
| Notes significant events after reporting period quarterly financial statements (text) | CurrentYTDDuration | Text · Plus | |
| Other information financial statements etc (text) | CurrentYTDDuration | Text · Plus | |
| Information about company which provides guarantee to reporting company (text) | FilingDateInstant | Text · Plus |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 10 of 10 passed
| balance sheet identity | pass |
| balance sheet identity | pass |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |